Arch Therapeutics, Inc. filed its 10-K on Dec 28, 2022 for the period ending Sep 30, 2022. In this report its auditor, Baker Tilly, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 USD | 0.00% | +9.47% | -85.64% |
1st Jan change | Capi. | |
---|---|---|
-85.64% | 46.22L | |
+8.38% | 12TCr | |
-6.40% | 1.1TCr | |
+1.56% | 888.06Cr | |
+36.32% | 545.48Cr | |
-21.55% | 474.19Cr | |
+8.20% | 343.51Cr | |
-7.69% | 283.63Cr | |
-8.42% | 215.38Cr | |
-5.20% | 211.04Cr |
- Stock Market
- Equities
- ARTH Stock
- News Arch Therapeutics, Inc.
- Arch Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt